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Mechanisms of proteinuria in diabetic nephropathy: A study of glomer-
ular barrier function. The fractional clearance of neutral dextrans (OD)
with Einstein-Stokes radii between 30 and 64 A was determined in
normal subjects (controls, N = 15) and in diabetic patients with heavy
proteinuria (advanced nephropathy, N = 16) or trace proteinuria (early
nephropathy, N = 8). When plotted on log normal probability coordi-
nates, the correlation between O and radius in controls and in early
diabetic nephropathy was linear, suggesting that glomerular pores form
one population with a normal distribution. In advanced diabetic
nephropathy, however, O for large molecules (radius > 46 A) was
elevated and departed from linearity suggesting a bimodal pore size
distribution within the glomerular membrane. A mathematical model
was devised, which revealed the mean fraction of glomerular filtrate
permeating the upper pore mode to be 0.009 0.002, and the pores to
be totally nondiscriminatory toward molecules with radii up to 64 A.
We conclude that the development of large pores (or defects) within the
glomerular membrane in advanced diabetic nephropathy permits the
unrestricted passage of large plasma proteins into the urine.
Mécanismes de Ia proteinurie au cours de Ia néphropathie diabétique:
étude du fonctionnement de Ia barrière glomérulaire. La clearance
fractionnelle de dextrans neutres (8) ayant des rayons d'Einstein-
Stokes entre 30 et 64 A était déterminé chez des sujets normaux
(contrOles, N = 15) et chez des diabétiques ayant une protéinurie
abondante (néphropathie évoluée, N = 16) ou a l'état de traces
(néphropathie debutante, N = 8). En coordonnées log normales, Ia
correlation entre 0D et le rayon Ctait linCaire chez les normaux et au
cours des néphropathies diabétiques débutantes suggerant que les pores
glomerulaires constituent une population de distribution normale. Ce-
pendant, au cours de Ia néphropathie diabétique dvoluée, O pour les
grosses molecules (rayon > 46 A) était élevée et s'écartait de La
linéarité, suggérant une distribution bimodale de Ia taille des pores de La
membrane glomCrulaire. En utilisant un modCle mathCmatique, on a
constaté qu'en moyenne Ia fraction de la surface representee par les
pores de grande taille était de 0,009 0,002, et que ces pores ne
discriminaient en rien les molecules dont le rayon atteignait 64 A. Nous
concluons que l'apparition de larges pores (ou defects) dans Ia mem-
brane glomérulaire au cours de Ia néphropathie diabetique évoluée
laisse un libre passage aux grosses protCines plasmatiques dans l'urine.
The magnitude of proteinuria may be used as a measure of the
severity of diabetic nephropathy. When a sensitive radio-
immunoassay has been applied to urine samples of patients with
insulin-dependent diabetes of recent onset, a slight but measur-
able increase in urinary albumin excretion (20 to 100 g!min)
was observed [1—3]. Ten or more years are likely to elapse after
the development of diabetes, however, before urinary albumin
excretion exceeds 100 g/min, a value above which convention-
al tests of proteinuria become positive [4—61. This increased
proteinuria heralds a gradual deterioration in glomerular func-
tion [7]. An insidious but progressive decline in glomerular
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filtration rate (GFR) to levels resulting in endstage renal failure
is accompanied by increasingly heavy proteinuria, which even-
tually reaches nephrotic proportions [7—10].
Typical of the most advanced stage of diabetic nephropathy is
a nonselective proteinuria with massive leakage into the urine
of large plasma proteins, the most copious of which are albumin
and immunoglobulin G (IgG) [11, 12]. Depletion of glomerular
sialoglycoproteins during the course of diabetic nephropathy is
predicted to result in reduction of the density of fixed negative
charges in the glomerular capillary wall [13, 14]. Accordingly,
the transglomerular passage of circulating polyanions, including
albumin (isoelectric point = 4.7), is likely to be enhanced.
Defective electrostatic barrier function is unlikely, however, to
account for the increased transglomerular passage of IgG, the
major subclasses of which are neutral or only weakly charged
(isoelectric point = 6,6 — 8.0) [15]. Moreover, determinations
of the effective molecular dimensions of IgG [16, 17] and of
mean pore size of the glomerulus [18—20] respectively, reveal
both to have a radius of approximately 55 A, with the result that
IgG should be effectively excluded from Bowman's space on
the basis of its size alone. The presence of large quantities of
IgG in urine samples of patients with diabetic nephropathy,
therefore, is suggestive of an alteration in the size-selective
properties of the glomerular capillary wall [20].
Our understanding of the mechanisms governing the permse-
lective properties of the glomerular capillary wall derive, in
part, from fractional clearances of macromolecules, in which
the clearance of a test macromolecule is compared to that of a
freely permeable reference marker, such as inulin. If both the
macromolecule and the reference marker are neither secreted
nor reabsorbed, then the fractional clearance of the macromole-
cule is equivalent to its glomerular filtrate-to-plasma water
concentration ratio. That ratio may be represented by the
sieving coefficient (0). Polydisperse neutral dextran which
meets the foregoing criteria for an ideal test macromolecule can
be used, therefore, to characterize the sieving properties of the
glomerulus [21].
In an earlier study of nephrotic patients with diabetic
nephropathy we found that relative to normal subjects, the
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transglomerular passage of neutral dextrans with Einstein-
Stokes radii (r) between 20 and 40 A was restricted, whence it
appeared that mean glomerular pore size might be paradoxically
reduced. The glomerular sieving coefficient of dextrans with r =
40 to 48 A, however, approached or slightly exceeded that in
normal subjects [11]. This evidence that the glomerular mem-
brane in diabetic nephropathy has a less sharp "cut-off" than
normal for large molecules is consistent with a bimodal distribu-
tion of pore size, the upper mode being relatively permeable to
large macromolecules with molecular dimensions similar to
those of large plasma proteins [2]. To test this hypothesis, we
studied transglomerular dextran transport in another group of
patients with diabetic nephropathy. We also devised a mathe-
matical model of the glomerular membrane to provide a means
for (1) interpreting changes in transglomerular dextran transport
in terms of membrane-pore structure and (2) relating such
transport changes to proteinuria.
Methods
Rationale. As stated previously, the observed changes in
dextran and plasma protein clearance which accompany the
advanced stage of diabetic nephropathy can be rationalized by
assuming the formation of a bimodal pore-size distribution
within the glomerular membrane, with the major fraction of the
glomerular filtrate passing through the small-pore component of
the distribution (which is essentially IgG impermeable), while
the minor large-pore component is solely responsible for IgG
leakage. This "two-population" membrane model is amenable
to mathematical analysis in which the experimentally-deter-
mined sieving curves are manipulated to allow independent
dtermination of the solute- and solvent-transport characteristics
of the two membrane populations. (See Appendix.)
A dextran-sieving curve representative of the glomerular
membrane in advanced diabetic nephropathy [11] is shown in
Figure 1. The solid curve describes the variation of the experi-
mentally measured sieving coefficients with r. As discussed in
the Appendix, this curve can, to a reasonable approximation be
regarded as the arithmetic sum of solute transport through the
small- and large-pore component of the membrane respectively,
and expressed as
0' °cr + Eq. 1
where 0' is the overall sieving coefficient for the whole glomeru-
lar membrane, 0. and 9 are the sieving coefficients for the
small-pore and large-pore portions of the membrane, respec-
tively; and 4) represents the fraction of the total GFR which
permeates the large-pore membrane area. 0,,, and is4' are
depicted as dashed lines in the left panel of Figure 1. It is
evident from this construction that, if the functional relation-
ship between 0(ff) and r could be independently established, it
would be possible to isolate the properties of the large-pore part
of the glomerular membrane by difference, and thereby esti-
mate its area fraction, 4), and characteristic sieving curve, Oq.
Such a manipulation of the sieving data is rendered feasible
by applying the observation that sieving curves for most natural
and synthetic ultrafiltration membranes including the glomeru-
lar capillary wall, plot as straight lines on log-normal probability
coordinates [20, 22]. Because at small values of r, the sieving
coefficient for the glomerulus in diabetic nephropathy is domi-
nated by the contribution of the small-pore part of the mem-
brane [that is, 0' 0(,,,,)], on log-normal probability coordinates
the low-r part of the sieving curve should be linear and
equivalent to The construction of Figure 1 then appears as
shown in the right hand panel. In this case, the difference
between the actual curve 0' and the linear approximation, 0(,),
is very nearly equal to 0()4) (Equation 1).
It now remains to independently determine 4) and the sieving
curve for the IgG permeable part of the membrane, 0(n). This
can be done by first plotting [0' — 0(j] vs. r on log-normal
coordinates. Since, as r— 0, 0(n) must approach 1.0, this curve
must approach a limiting asymptote equal to 4) (Fig. 1, right
panel). Once 4) is determined, dividing the computed values of
0()4 by 4) obviously yields the desired sieving curve, 0(s).
Patient population. Twenty-four patients with insulin-depen-
dent diabetes mellitus of more than 10 years' duration and
ophthalmoscopic evidence of diabetic retinopathy were studied
by a differential macromolecule clearance technique. They
were arbitrarily separated into two groups by the absence or
presence, respectively, of heavy proteinuria (>1 g/24 hr). Eight
patients comprised the group with slight or absent proteinuria
and were designated early diabetic nephropathy. The remaining
16 patients had heavy proteinuria and were designated ad-
vanced diabetic nephropathy. Fifteen healthy volunteers, simi-
lar in age to patients with advanced diabetic nephropathy, and
who were free of renal disease and normotensive, served as
controls. The study protocol was approved by the Stanford
University Committee for the Protection of Human Subjects in
Research. Informed consent was obtained from each patient
and volunteer prior to study.
Study protocol. Each patient and volunteer voided spontane-
ously after water diuresis had been established by oral water
loading. A priming dose followed by a constant infusion of
inulin and para-aminohippurate (PAH) was administered to
permit determination of the rates of glomerular filtration (GFR)
and of effective renal plasma flow (ERPF) from the respective
urinary clearances of each marker as described previously [231.
Dextran-40 (Rheomacrodex, Pharmacia Fine Chemicals, AB,
Uppsala, Sweden) 130 mg/kg was administered by slow (—10
mm) intravenous injection immediately following the inulin
/PAH prime. At the end of a 40- to 60-mm equilibration period,
the bladder was emptied by voiding, after which three carefully
timed 20- to 30-mm urine collections were made. From urine
and plasma obtained during the first of these timed collections,
fractional clearances (or sieving coefficient) of Dextran-40 (OD)
were computed, using the equation
= [(U/P)D]/[(U/P)1fl1 Eq. 2
where (U/P)0 and (U/P)1 refer to the urine-to-midpoint plasma
concentration ratios of dextran and inulin, respectively. The
same urine and plasma samples were used for the determination
of the urinary excretion rate and plasma concentration of
albumin and IgG respectively. GFR and ERPF were expressed
as the mean value of all three timed urine collections.
Laboratory methods. For the calculation of GFR, inulin
concentration of urine and plasma was determined using the
autoanalyzer method of Fjeldbo and Stamey [24]. This method
uses the fructose-specific reagent resorcinol, which is uninflu-
enced by the presence of dextran. The autoanalyzer method of
Harvey and Brothers was used for the determination of PAH
[25].
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Fig. 1. Hypothetical sieving curve for a glomerular membrane in
advanced diabetic nephropathy plotted on semilogarithmic coordinates
(left panel) and log-normal probability coordinates (right panel). Sym-
bols used are 0', overall sieving coefficient for the whole glomerular
membrane; (0),, and (0) are sieving curves for small- and large-pore
components of the glomerular membrane, respectively; , fraction of
total GFR permeating large pores; ESR, Einstein-Stokes radius. For
detailed explanation see text.
Separation of Dextran-40 and inulin in plasma and urine into
narrow fractions (approximately 2 to 4 A) was accomplished by
gel permeation chromatography using a column (93.5 cm long X
1.6 cm I.D.) packed with Sephacryl S-300 and calibrated with
three narrow dextran fractions of known molecular size provid-
ed by the manufacturer (Pharmacia Fine Chemicals AB, Uppsa-
la, Sweden). Using 0.3% buffered saline as eluent, 2.6 ml eluted
fractions were collected with an automatic fractionator (Gilson
Model S-80). The void volume (V0) was determined with Blue
Dextran, and the fractional volume available to the solute (Kay)
was calculated as
Kay = (Ye - V0)/(V - V0) Eq. 3
where Ve is the elution volume of the solute and Vt the total
volume of the gel column [26]. Einstein-Stokes radii (r) for
individual dextran fractions were calculated from Kay [27].
Following gel permeation chromatography of plasma and urine,
eluted fractions were assayed for dextran and inulin concentra-
tions using a modification of the autoanalyzer anthrone method
of Scott and Melvin [28]. Most of the eluted inulin had radii of
13 to 15 A, and fractions containing molecules in this size range
were used to calculate the (U/P)1 ratio for subsequent determi-
nation of fractional clearances. It should be noted that (UIP)1 as
determined by the anthrone method was not significantly differ-
ent from that obtained by the resorcinol method.
Urine samples were concentrated by between 25- and 100-
fold and tested, respectively, against antisera specific for hu-
man IgG heavy chains and for lambda and kappa light chains
(Meloy Labs Inc., Springfield, Virginia) using the double diffu-
sion Ouchterlony technique [11]. Reactions of identity with all
three antigens were the same as those obtained with an isolated
preparation of human polyclonal IgG, indicating that heavy
chain-reactive urinary IgG in patients with diabetic nephrop-
athy represents the intact plasma protein. The concentrations of
IgG and albumin in unconcentrated urine were then determined
by radial immunodiffusion using low level immunodiffusion
plates as described previously [111. These plates permit the
measurement of IgG and albumin over a concentration range of
1 to 25 and 4 to 100 mg/dl, respectively.
Statistical analysis. All results are expressed as the mean
SEM. Student's t test for unpaired data was used to evaluate the
significance of inter-group differences observed.
Results
Renal function and urine protein excretion (Table 1, Fig. 2).
That the magnitude of proteinuria provides a reasonable basis
for classifying patients with diabetic nephropathy into early and
advanced categories is suggested by the respective values for
GFR and ERPF. Whereas GFR and ERPF in patients with early
diabetic nephropathy and slight proteinuria were similar to
those in normal subjects (122 20 and 412 129 vs. 100 9
and 469 41 mljmin/l.73m2, respectively); the corresponding
values in patients with advanced diabetic nephropathy and
heavy proteinuria were significantly depressed below normal to
27 6 and 116 24 ml/min/1.73m2, respectively (P < 0.01). An
equally striking relationship between magnitude of proteinuria
and overall kidney function was observed in individual patients.
Although the precise contribution of tubular protein reabsorp-
tion to the excretion rate of filtered proteins in patients with
primary glomerular diseases is unknown, the rate at which a
given protein is excreted per ml GFR may be regarded as a
measure of glomerular permeability to that protein [29]. A plot
of albumin and IgG excretion per ml GFR against GFR is
illustrated in Figure 2. Each test protein was undetectable or
present in trace quantities only in the urine of patients with
early diabetic nephropathy and normal GFR. With advanced
diabetic nephropathy, however, the observed rate at which
each protein was excreted per ml GFR was proportional to the
degree to which GFR was depressed. For all patients with
advanced diabetic nephropathy and those with early diabetic
nephropathy in whom protein excretion was measurable by
radial immunodiffusion, the inverse relationship between the
respective rates of albumin and IgG excreted per ml GFR and
GFR was strongly correlated (r value = 0.90 and 0.78, respec-
tively).
Fractional dextran clearances (Table 2, Figures 3 and 4). The
sieving curve for dextrans in the r range 30 to 64 A (Kay =0.5 to
0.2) in advanced diabetic nephropathy was different from that in
normal control subjects. The sieving coefficients for dextran
molecules of relatively small r were depressed below normal.
The opposite was true of sieving coefficients for dextrans of
large r, which were elevated above normal (Fig. 3). These
differences from normal were statistically significant for the
smallest (r = 30 to 36 A) and largest (r = 60 and 64 A) dextrans
examined (Table 2). In early diabetic nephropathy a slight but
similar trend away from normality failed to reach statistical
significance (Table 2). The small and large r ends of the sieving
curve in advanced diabetic nephropathy were also respectively
depressed and elevated relative to early diabetic nephropathy.
Only the elevation of the sieving coefficients for the largest
dextran fractions in advanced relative to early diabetic
nephropathy, however, reached statistical significance (Table
2).
In addition to the absolute elevation of the large r portion of
the sieving curve in patients with advanced diabetic nephrop-
athy, its configuration was different from that in patients with
early diabetic nephropathy or that of normal control subjects,
respectively. When plotted on log-normal probability coordi-
nates the relationship between °D and r approximated linearity
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Table 1. Renal function and urinary protein excretions
Age
years
GFR ERPF UAbV lJigoV
—____________
p.g/minmlIminII.73m2
Normal control (C) 49 100 469 2.7 0.5
(N = 15)
Early DN 33 122 412 203 7.8(N=8)
P vs. C <0.02 NS NS NS NS
AdvancedDN 45 27 116 3,786 570
(N= 16)
P vs. C NS <.01 <.01 <.001 <.001
P vs. early DN <0.05 <.001 <.05 <.001 <.001
All values are expressed as mean SEM.
Abbreviations are UV, urine excretion rate; NS, not significant; GFR, glomerular filtration rate; ERPF, effective renal plasma flow; DN, diabetic
nephropathy; UAJbV, urinary excretion rates of albumin; UigoV, urinary excretion rates of IgG.
Table 2. Fractional dextran clearances
Fig. 2. Relationship between protein excretion
rate per milliliter glomerular filtrate and GFR
in patients with diabetic nephropathy. Albu-
min excretion is plotted in left panel and IgG
excretion in right panel, respectively. Patients
with advanced diabetic nephropathy are de-
picted as closed circles and those with early
diabetic nephropathy as open circles. Unmea-
surable protein excretion rates are depicted in
the shaded zone in the lower right hand cor-
ner.
30 32 34 36 38 40 42 44 46 50 53 57 60 64
A
Normal controls (C)
N = 15
Mean 0.626 0.471 0.350 0.256 0.191 0.141 0.103 0.077 0.058 0.035 0.022 0.015 0.009 0.006
SEM 0.040 0.031 0.023 0.016 0.012 0.009 0.007 0.005 0.004 0.003 0.002 0.003 0.001 0.001
Early DN
N= 8
Mean 0.475 0.378 0.297 0.237 0.181 0.139 0.105 0.081 0.061 0.039 0.025 0.016 0.011 0.007
SEM 0.046 0.039 0.032 0.029 0.021 0.016 0.013 0.011 0.009 0.006 0.004 0.002 0.001 0.001
P vs. C <0.25 NS NS NS NS NS NS NS NS NS NS NS NS NS
Advanced DN
N = 16
Mean 0.400 0.318 0.246 0.196 0.155 0.122 0.095 0.074 0.059 0.039 0.027 0.020 0.016 0.015
SEM 0.029 0.024 0.020 0.015 0.013 0.011 0.009 0.007 0.006 0.004 0.003 0.003 0.002 0.002
P vs. C <.001 <.001 <.005 <.02 NS NS NS NS NS NS NS NS <.005 <.001
P vs. early DN NS NS NS NS NS NS NS NS NS NS NS NS <.05 <.005
Abbreviation is DN, diabetic nephropathy.
1000
r0.90 r = 0.78
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GFR, ml/min/1.73m2
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Fig. 3. Fractional dextran profile (or dextran sieving curve) for the
glomerulus in healthy volunteers () and in subjects with advanced
diabetic nephropathy (•). All results are expressed as mean SEM.
The asterisk equals P < 0.01.
in the latter two populations (Fig. 4). In advanced diabetic
nephropathy, however, elevation of 0 for molecules with r>
46 A resulted in an upward displacement of the latter part of the
sieving curve with the result that the relationship between 0D
and r was curvi-linear (Fig. 4).
Analysis of glomerular macromolecule transport in advanced
diabetic nephropathy (Table 3). The measured variation of 0
with r (or 0'), and the linear extrapolation of the early part of the
sieving curve (Or,) for each subject with advanced diabetic
nephropathy was plotted on log-normal probability coordinates
in the manner of Figure lB. Upward deflection above linearity
of three or more of the largest dextran fractions permitted the
difference between 0' and 0 (or °4)) to be estimated in 13
instances (Equation 1). From the limiting asymptote of the
relationship between r and 04 the fraction of glomerular
filtrate entering Bowman's space through an hypothetical upper
mode of large pores, 4), was estimated to average 0.009 0.002
(range 0.003 to 0.055). 1)ividing 04) by 4) revealed the upper
mode to be totally non-discriminatory with respect to dextrans
of all sizes examined (that is, 0 1.0).
By assuming that like dextrans of equivalent size, albumin
and IgG were also unrestricted, the predicted load of each
protein filtered through an upper mode of large pores [FL()]
was estimated from the product of the respective plasma
protein concentration and (GFR). This computation yielded
values for FL(6) albumin of 5813 1372 and for FL(B)15G of 1780
e
0.01
0.001
00001- 304050 70
Fig. 4. Fractional dextran clearances (or dextran sieving coefficients)
plotted as a function of dextran Einstein-Stokes radius on log-normal
probability coordinates for healthy volunteers (Lx, left), early diabetic
nephropathy (0, middle), and advanced diabetic nephropathy (•,
right). The linear extrapolation (or 0,) in advanced diabetic nephropa-
thy reflects the sieving properties of the small-pore component of the
membrane.
559 p.g/min. These values are in excess of the measured
urinary excretion rates of albumin (3813 569) and IgG (542
140 g/min) by 1.5 and 3.3-fold, respectively.
Fractional reabsorption of filtered albumin and IgG have been
shown to be similar 1301. The relatively small disparity between
albumin excretion rate and its filtration rate through large pores
may be an indication, therefore, of a larger filtered load of
albumin than can be accounted for by permeation through an
upper mode of large pores alone. In support of this possibility is
the relationship between the individual values for FL(S) and
protein excretion rate (Table 3). The measured rate of IgG
excretion was similar to or less than FL()IgG in all 13 patients.
By contrast, albumin excretion rate exceeded FLU3)albumin by 20
to 154% in five instances. Thus, whereas filtration through a
small upper mode of nondiscriminatory pores could, in theory,
account entirely for the observed rate of IgG excretion, an
additional contribution to albumin filtration through the lower
pore mode must be invoked to explain the observed rate of
albumin excretion in some patients with advanced nephrop-
athy.
Discussion
Proteinuria is widely regarded as the hallmark of diabetic
nephropathy and is the commonest clinical manifestation in
patients with diabetic glomerulosclerosis [31]. Its prevalence,
however, does not parallel morphological alterations in the
glomerular capillaries. Demonstrable widening of the glomeru-
lar basement membrane and expansion of the mesangium are
evident by electronmicroscopy years before proteinuria be-
comes manifest [32, 33]; an even more striking alteration of
these glomerular structures, easily diagnosed by light microsco-
py, has been reported in patients without proteinuria [31, 34—
37]. From the long duration of insulin-dependent diabetes (>10
years) and the association with diabetic retinopathy, it seems
probable that the eight patients categorized as early diabetic
nephropathy in this study have structural abnormalities of their
1.0 —
0.1
*
*
*
*
0.70
0.50
0.30
0.10
I I I I I
30 4050 70
Einstein-Stokes radius, A
I I I I
304050 70
0
0.003
0.01
* *
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Table 3. Analysis of glomerular macromolecule transport in advanced
diabetic nephropathy
.Patient
no.
4 FL()aIhumin" Ualbumin Vc FL()IgcJ' UIgG V'—_
p.glmin
1 0.007 8,206 2,669 1,381 208
2 0.004 4,201 1,488 1,106 102
3 0.004 3,608 3,335 1,335 297
4 0.005 5,009 3,864 1,032 320
5 0.003 3,729 2,599 662 41
6 0.006 15,437 3,790 7,718 100
7 0.018 2,049 4,437d 1,303 1,341
8 0.006 1,885 3,075" 410 409
9 0.015 1,226 909 751 203
10 0.014 3,036 7,720" 1,436 1,600
11 0.007 5,292 6,351d 1,215 950
12 0.020 4,978 6,840" 603 537
13 0.055 16,915 2,487 4,193 942
N = 13
Mean 0.009
SEM
5,813
1,372
3,813 1,780 542
4) is the fraction of total GFR filtered through large pores.
b FL() is the predicted load of protein filtered through large pores,
g/min.
UV is the urine excretion rate, p.g/min.
"UV exceeds FL(13 for albumin.
glomerular capillaries [38—401. However, as judged by a normal
rate of water ultrafiltration, unremarkable permselective prop-
erties toward neutral dextrans and absent or scant protein
leakage into the urine, no overt impairment of glomerular
function could be detected. The relationship between glomeru-
lar structure and function in the early stages of diabetic
nephropathy therefore remains obscure.
In contrast is the strong association between heavy protein-
uria in advanced diabetic nephropathy and light microscopic
changes typical of the diffuse and sometimes of the nodular
form of diabetic glomerulosclerosis [31, 37]. The presumptive
presence of severe diabetic glomeruloscierosis in the 16 patients
categorized as advanced diabetic nephropathy provides a likely
explanation for the observed reduction in the rate of water
ultrafiltration. Thus a greatly expanded mesangial matrix, by
obliterating many capillary lumina, would likely result in a
reduction of surface area available for filtration [311. As judged
by enhanced filtration of large dextran molecules (>46 A), there
also exists a defect in the size-selective glomerular barrier to
macromolecule filtration.
When plotted on log-normal probability coordinates, the
variation of experimentally measured dextran sieving coeffi-
cients with r in normal volunteers is described by a straight line
(Fig. 4). This finding is in accord with earlier observations in
normal man [20, 41] and in various mammalian species includ-
ing the rat [22] and the rabbit [42]. The same also holds true for
patients with early diabetic nephropathy (Fig. 4). This type of
sieving coefficient correlation implies a reasonably narrow
unimodal distribution of pore size [22]. Any significant depar-
ture from linearity on these coordinates, as is evidenced by
patients with advanced diabetic nephropathy, may thus be
construed to indicate a bimodal or more complicated distribu-
tion of pore size within the glomerular membrane [22].
For the sake of simplicity, we have assumed a bimodal pore
size distribution and employed a model of the glomerular
membrane in the advanced stage of diabetic nephropathy which
provides a means for interpreting the observed changes in the
transglomerular transport of polydisperse neutral dextrans in
terms of a change in membrane-pore-structure. According to
this model, the pathologic glomerular membrane of advanced
diabetic nephropathy is composed of a parallel array of two
radically different pore structure components. The main com-
ponent (that is, the larger part of the total glomerular membrane
area) is a "small-pore" ultrafilter, similar in ultrastructure to
that of the normal glomerular membrane, and is responsible for
the retention of dextrans of small r. The minor component (that
is, the smaller part of the total membrane area) is postulated as
being a "large-pore" ultrafilter, through which large (and small)
macromolecules are able to penetrate. The fraction of the total
GFR, which passes through the "large-pore" component (de-
fined as 4)) is computed to be less than 0.01, meaning that much
less than 1% of the total surface area of the glomerular
membrane is composed of such "defective" membrane. The
sieving curve computed for this damaged segment of the
membrane (O() vs. r) suggests that dextran molecules of r 64
A are unrestricted in passage; whence, this membrane compo-
nent is presumed to be highly permeable to plasma proteins as
well.
Although the theoretical analysis from which these mem-
brane parameters have been derived should not be regarded as a
representation of glomerular morphology, it is interesting to
note that at least two processes that might cause a focal
disruption of the glomerular filtration barrier have been ob-
served in advanced diabetic nephropathy. These are a focal foot
process degeneration with detachment of epithelial cells from
and denudation of the underlying glornerular basement mem-
brane [43], and the development of electron lucent "moth-
eaten" areas within the glomerular basement membrane [44].
Either process may provide a structural basis for large mem-
brane defects which do not discriminate among size or charge of
macromolecules and behave as an upper mode of large protein-
permeable pores.
Our theoretical analysis requires two assumptions: (1) IgG (r
= 55 A) is too large to permeate the small-pore component of
the membrane, and (2) the large-pore component does not
discriminate between IgG and a dextran molecule of equivalent
size. Based on these assumptions, the predicted load of IgG
filtered through the large-pore component of the membrane
(FL()IgG) is of sufficient magnitude to account for the observed
urinary excretion of IgG, which it exceeds by a factor of 3.3 on
average. The fractional reabsorption of only two thirds of
filtered IgG, implicit in the foregoing computation, is consistent
with a saturable mechanism for the uptake of filtered proteins
by the proximal tubule epithelium [45, 46]. It should be empha-
sized, however, that indirect clearance techniques in the rat
suggest that plasma proteins are substantially more restricted
by the normal glomerular capillary wall than dextrans of
equivalent size and similar charge [47]. This disparity has been
ascribed to asphericity and molecular compliance of dextran
molecules under shear, with the result that their effective
molecular dimensions during transglomerular permeation are
smaller than those estimated by gel permeation chromatogra-
phy [48]. If the clearance of proteins and equivalent-sized
dextrans through the large-pore component of the glomerular
membrane in advanced diabetic nephropathy is similarly dispar-
ate, then our computation of the load of IgG filtered through
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large pores will be in excess of the true value, while the actual
fraction of IgG reabsorbed will be correspondingly smaller.
There is now a large body of evidence which indicates that
the glomerular capillary wall excludes macromolecules on the
basis of charge as well as size [49—51]. Given the absence of a
detectable upper mode of protein-permeable pores and tenden-
cy toward a shift in the distribution of pores to those of smaller
size or lower density in early diabetic nephropathy, it is
tempting to postulate that the relatively minor leakage of
albumin into the urine is due to electrostatic barrier dysfunc-
tion. Thus, reduced electrostatic retardation of the relatively
small (r = 36 A) but highly anionic albumin molecule will
enhance its permeation across a glomerular capillary wall
depleted of its fixed negative charges. The finding in some
patients with advanced diabetic nephropathy that the rate of
albumin excretion exceeds the predicted load of albumin fil-
tered through the large-pore component of the glomerular
membrane (FL()aIbumin, Table 3) suggests that defective elec-
trostatic barrier function in the small-pore component of the
glomerular membrane also contributes to albuminuria in these
latter patients. In keeping with this interpretation is the finding
from cytochemical and compositional studies of glomeruli from
patients with diabetic nephropathy that glomerular polyanion is
depleted [13, 14].
We offer the following hypothesis, based on the foregoing
analysis and observations, to explain the pathogenesis of pro-
teinuria in diabetic nephropathy. During the early stages of the
disease, progressive widening of the glomerular basement mem-
brane may be accompanied by loss of fixed negative charges in
the glomerular capillary wall. The relatively small initial rate of
albumin leakage into the urine could result from an ensuing loss
of electrostatic retardation. In keeping with the observations of
others, it may be predicted from the Y intercept of the regres-
sion line for albumin excretion vs. GFR (Fig. 2) that albumin-
uria will develop while GFR is still within the normal range (112
mI/mm) [1—3, 7]. Although urinary IgG excretion is not measur-
ably enhanced at relatively high values of GFR, a modest
increase in glomerular permeability with enhanced tubular
reabsorption of this large protein cannot be excluded. With
increasing glomerular damage, a second population of large
pores develops within the glomerular membrane, and permits
the unrestricted transmembrane passage of large plasma pro-
teins, including IgG. From the Y intercept of the regression line
for urinary IgG excretion vs. GFR, this upper mode of pores
and hence IgG leakage into the urine is predicted to become
apparent once GFR has declined to approximately 50% of
normal (60 mi/mm, Fig. 2). Hereafter progressive damage to
both pore modes eventuates. As the small-pore mode becomes
progressively depleted of its negative charges, the transglomer-
ular transport of albumin and other anionic proteins of relative-
ly small r becomes enhanced. Simultaneously, an increasing
size and charge-independent flux of plasma proteins through the
upper mode ensues, the rate of which is determined, in part, by
the sum of all the defects (or large pores) that have developed in
the membrane during the course of its deterioration. The
appearance of massive proteinuria and the nephrotic syndrome
as a near-terminal event during the evolution of diabetic
nephropathy [8—101 implies that in the final stages of the lesion,
the increase in protein clearance must be disproportionately
large relative to the simultaneous reduction in GFR. It remains
to be determined whether this terminal enhancement of frac-
tional protein clearance is a consequence of (1) an absolute
increase in the filtered protein load, or of (2) a decline in
fractional reabsorption due to saturation of the tubular protein
transport mechanism. It is tempting to speculate, however, that
a combined contribution by each of these determinants of
fractional protein clearance must be required to explain ne-
phrotic-range proteinuria in diabetic nephropathy even when
GFR has declined to values so low that the initiation of dialysis
therapy must be contemplated.
Appendix
For a parallel-array of two structurally different membranes,
water and solute-flow through the glomerular wall can be
described as follows: Let J(,) = Water flux through the
retentive (small-pore) membrane area (ml . cm2 sec) and
= Water flux through the lgG permeable (large-pore) area.
Then:
GFR = Jw(cr)A(,j) + J()A() Eq. Al
Where A(,,) and A() are the areas of small- and large-pore
components of the membrane, respectively, (in cm2), and
A(1) + A() = A(T) Eq. A2
Where A(T) is the total glomerular membrane area in cm2.
=Let 4) = = const
JW(O)A(() + JW)A(13 GFR
Where 4) = Fraction of GFR which permeates the large-pore
membrane area.
Hence:
and
JWS)A = GFR 4)
Jw(cr)A(cr) = GFR (I — 4))
Eq. A3
Eq. A4
Now, let Js be the flux of a specified macrosolute through the
glomerular membrane under conditions in which its plasma
concentration is Cp. If is the sieving coefficient of that
solute by the retentive (small-pore) membrane area, and O(), its
value for the large-pore membrane area, mass conservation
requires that
Js = 0' Cp (GFR) = O(,y)Cp JW(o(o + O()Cp W((3)
= CF (GFR) Eq. AS
Where CF Solute concentration in the glomerular filtrate, and
0' = Overall sieving coefficient of that solute for the
glomerular membrane (0' = CF/Cp)
Combining equations A3, A4, and AS we have:
0' = 0,(l — 4)) + 0(0)4) Eq. A6
Now, both 0(,) and 0(e) decline from unity toward zero as the
size of permeating solute molecule increases, although °(a) does
so far more rapidly than 0(n); under these circumstances, the
following limiting simplifications of equation A6 apply:
lim 0' = 0() + 4)[l — 0(ff)] Eq. A70'F'
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If, in addition 4) 0, then equation A6 reduces to
0' +
where °(cr) = f()r, and 0(n) = f()r, where f(g) and f() are the
functional relationships between 0 and r of the permeating
molecule for the two types of membrane.
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